跳至主要内容
临床试验/NCT06657053
NCT06657053尚未招募不适用

Facteurs De Risques De Récidive D'épistaxis Chez L'adulte

University Hospital, Grenoble1 个研究点 分布在 1 个国家目标入组 145 人开始时间: 2024年11月2日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
145
试验地点
1
主要终点
Survival without bleeding

研究概览

简要总结

We study all patients admitted to the Emergency Department in the Institution between 01/2022 and 07/2023. The information about the recurrence of nose bleeding was searched on their medical file and by calling the patient to confirm ou get the information. Thus, several potentiel risk factors were studied.

The relation between recurrence and those factors were studied at first individually and then all the significant ones were analyzed with a multivarious statistical test.

详细描述

We study all patients admitted to the Emergency Department in the Institution between 01/2022 and 07/2023. The information about the recurrence of nose bleeding was searched on their medical file and by calling the patient to confirm ou get the information. Thus, several potentiel risk factors were studied : oral anticoagulants, sex, INR, anti-platelets drugs, diabetes, obesity, arterial hypertension, heart failure, hemoglobin at the admission, history of chronic rhinosinusitis, appointment with an ENT during the acute bleeding, sleep apnea, age, anatomic abnormality, recent surgery within 2 months, previous admission within 30 days in the emergency department, nasal trauma.

The relation between recurrence and those factors were studied at first individually and then all the significant ones were analyzed with a multivarious statistical test.

This study aim to provide a pronostic score of recurrence that can happen after the 3 fisrt weeks after the event. When a recurrence happens before 3 weeks, this was considered to be a non control of the bleeding episode.

This score will be then tested on our cohort to evaluate specificity and sensibility.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient who is admitted at the emergency department between 01/2022 and 07/2023 for nose bleeding.
  • Age over 18 yo

排除标准

  • Opposition to be included
  • Patient who has not his willness to provide opposition to participate.opposition

结局指标

主要结局

Survival without bleeding

时间窗: 1 year

Measuring the delay between the first epistaxis and a recurrence.

次要结局

未报告次要终点

研究者

发起方
University Hospital, Grenoble
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验